Facilitating informed choice, consumer protection and market harmonisation are the priority, says an industry group in response to a document evaluating claims made on plants and their preparations.
Blackmores has published a new whitepaper on nutrition guidelines for strengthening the immune system, preventing and treating respiratory tract infections – designed specifically for pharmacists.
The Association for the Cannabinoid Industry (ACI) has received clarification from the Food Standards Agency (FSA) regarding updated deadlines set for Cannabinoid (CBD) firms to apply for Novel Foods status.
While probiotic supplementation cannot prevent asthma or wheezing, it may improve lung function and asthma control in infants, according to a new systematic review.
The European Commission (EC) makes available a working document that describes the objectives of the nutrition and health claim regulations made on plants and their preparations for food use as ‘not fully attained’.
Researchers from East Asia are urging more research and clinical studies of the Japanese herbal medicine, Kampo, as a treatment for frailty, as part of a push to increase awareness in global markets.
The European Food Safety Authority (EFSA) gives its thumbs up to a botanical extract and a single‐cell microalga, concluding that these two supplement ingredients are safe to use at the proposed levels.
It is "inconceivable" that immunity will not remain high on the list of health priorities when this pandemic ends and now is the time to create more "convincing experiences" to ensure trial turns into adoption, according to food and...
Scientists have identified a link between the outcome of COVID-19 disease and dietary selenium – found in fish, seafood, meat, poultry, and cereals. FoodNavigator hears from lead researcher Professor Margaret Rayman, from the University of Surrey, to...
Diabetic patients who adopt a nutrition therapy consisting of whey protein and monounsaturated fatty acids (MUFA) have lower fasting blood glucose during the one-month long Ramadan fasting period, a clinical trial in Malaysia has shown.
A curcumin and artemisinin-based oral spray has been proposed as a treatment for COVID-19 patients and a clinical trial will be conducted, ASX-listed phytocannabinoid firm MGC Pharmaceuticals has revealed.
The US Food and Drug Administration has issued an additional six warning letters in recent days on coronavirus claims. The letters coincide with an industry coalition raising a red flag on the growing flood of such claims on dietary supplement-type products.
Holland & Barrett staff have set up a petition, signed by thousands of staff and customers, begging the company to close its stores during the coronavirus pandemic as they argue their lives and the lives of customers are being put at risk.
A coalition of dietary supplement industry trade associations have come out in support of FDA actions against fraudulent coronavirus treatment claims and have urged retailers to not stock products with such claims on their labels.
